Michael Cerniglia
Internal Medicine · Denver, CONPI 1386106284
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,384, more than ten times the $106 reported in 2022. Among internal medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $30.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$485
- Sanofi$272
- Ipsen Biopharmaceuticals, Inc$200
- AstraZeneca$195
- Novartis$194
- Johnson & Johnson$169
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,14495%
- Education$1835%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $485 |
| Sanofi | 11 | $272 |
| Ipsen Biopharmaceuticals, Inc | 3 | $200 |
| AstraZeneca(2 entities) | 10 | $195 |
| Novartis | 7 | $194 |
| Johnson & Johnson | 7 | $169 |
| Merck | 6 | $157 |
| Karyopharm Therapeutics Inc. | 2 | $156 |
| Rigel Pharmaceuticals, Inc. | 2 | $145 |
| Daiichi Sankyo Inc. | 6 | $120 |
| Incyte Corporation | 4 | $117 |
| Bristol Myers Squibb | 4 | $116 |
| Boston Scientific | 1 | $106 |
| Pfizer | 4 | $100 |
| Abiomed | 1 | $92 |
| EMD Serono, Inc. | 2 | $85 |
| Puma Biotechnology, Inc. | 3 | $73 |
| ADC Therapeutics America, Inc. | 3 | $71 |
| Servier Pharmaceuticals LLC | 3 | $70 |
| Jazz Pharmaceuticals Inc. | 2 | $63 |
| Genentech USA, Inc. | 2 | $53 |
| Amgen | 2 | $44 |
| Stemline Therapeutics Inc. | 1 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Exelixis Inc. | 1 | $31 |
| Agios Pharmaceuticals, Inc. | 1 | $28 |
| Blueprint Medicines Corporation | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Deciphera Pharmaceuticals Inc. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,327 in reported general payments places this provider in the 90th percentile of 1,430 internal medicine providers in Colorado.
Other internal medicine in Denver
- Kenneth OleszekDenver$60K
- Robert KeithDenver$49K
- Elena AnisimovaDenver$36K
- Chase BlackfordDenver$30K
- Matthew KoslowDenver$21K
- Katherine TsaiDenver$15K
- Saurabh MangalikDenver$14K
- David MellmanDenver$12K
- Cara DawsonDenver$11K
- Jason HenryDenver$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.